|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1785807374 |
| 003 |
DE-627 |
| 005 |
20230427062145.0 |
| 007 |
tu |
| 008 |
220112s2021 gw ||||| m 00| ||ger c |
| 035 |
|
|
|a (DE-627)1785807374
|
| 035 |
|
|
|a (DE-599)KXP1785807374
|
| 035 |
|
|
|a (OCoLC)1304805909
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 616.994
|q DE-101
|
| 082 |
0 |
4 |
|a 610
|q DE-101
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Hartmann, Sarah
|d 1988-
|e VerfasserIn
|0 (DE-588)118272812X
|0 (DE-627)1662886888
|4 aut
|
| 245 |
1 |
0 |
|a Bedeutung der therapeutischen Ziele ASCL1 und PD-L1 in Hotspots des neuroendokrinen Prostatakarzinoms
|c vorgelegt von Sarah Hartmann ; Referent: Priv.-Doz. Dr. med. Jost von Hardenberg
|
| 264 |
|
1 |
|a Heidelberg
|c 2021
|
| 300 |
|
|
|a 86 Blätter
|b Diagramme, Illustrationen
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-Universität Heidelberg
|d 2021
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Hardenberg, Jost von
|d 1982-
|e AkademischeR BetreuerIn
|0 (DE-588)1020494328
|0 (DE-627)688149278
|0 (DE-576)360578241
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20220112
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2019
|
| 998 |
|
|
|g 118272812X
|a Hartmann, Sarah
|m 118272812X:Hartmann, Sarah
|d 60000
|d 60001
|e 60000PH118272812X
|e 60001PH118272812X
|k 0/60000/
|k 1/60000/60001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1785807374
|e 4034199822
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"type":{"bibl":"thesis"},"recId":"1785807374","corporate":[{"role":"dgg","roleDisplay":"Grad-verleihende Institution","display":"Universität Heidelberg"}],"language":["ger"],"person":[{"family":"Hartmann","given":"Sarah","display":"Hartmann, Sarah","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Hardenberg, Jost von","roleDisplay":"AkademischeR BetreuerIn","role":"dgs","family":"Hardenberg","given":"Jost von"}],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2021"],"title":[{"title":"Bedeutung der therapeutischen Ziele ASCL1 und PD-L1 in Hotspots des neuroendokrinen Prostatakarzinoms","title_sort":"Bedeutung der therapeutischen Ziele ASCL1 und PD-L1 in Hotspots des neuroendokrinen Prostatakarzinoms"}],"physDesc":[{"noteIll":"Diagramme, Illustrationen","extent":"86 Blätter"}],"name":{"displayForm":["vorgelegt von Sarah Hartmann ; Referent: Priv.-Doz. Dr. med. Jost von Hardenberg"]},"origin":[{"publisherPlace":"Heidelberg","dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"id":{"eki":["1785807374"]}}
|
| SRT |
|
|
|a HARTMANNSABEDEUTUNGD2021
|
